학술논문
Comparison of non-medication-related osteonecrosis and medication-related osteonecrosis of the jaw: a pilot study
이용수 0
- 영문명
- 발행기관
- 대한구강악안면외과학회
- 저자명
- Ilgin Ari Ecem Usman Selen Adiloğlu Alper Aktaş
- 간행물 정보
- 『대한구강악안면외과학회지』제51권 제3호, 151~160쪽, 전체 10쪽
- 주제분류
- 의약학 > 일반외과학
- 파일형태
- 발행일자
- 2025.06.30
국문 초록
Objectives: This study aimed to compare composite radiographic index (CRI-index) findings of medication-related osteonecrosis of jaws (MRONJs) and non-medication related osteonecrosis of jaws (n-MRONJs) and predict factors predictive of recurrence and healing delays.
Materials and Methods: Patients referred to our clinic for stage 2 and 3 MRONJ and n-MRONJ between 2020 and 2023 were included in this study. Microorganisms were isolated in samples of excised bone obtained from the adjacent bone by surgery. CRI-index was evaluated using radiological data. Patient age, sex, causes and localization of osteomyelitis, as well as intraoperative and postoperative complications were recorded.
Results: There were no statistically significant differences in CRI-index score between the two groups (P>0.05). Presence of actinomyces colonies was not a significant predictor of recurrence or healing status. Furthermore, the presence of actinomyces colonies was not predictive of recurrence in the MRONJ group (P=0.035); however, the use of the antiresorptive agent denasumab was found to be a risk factor for recurrence in the MRONJ group (P=0.035).
Conclusion: Radiological and clinical findings were similar for MRONJ and n-MRONJ patients. However, although treatment methods for these two groups is almost identical, the follow-up process can vary. Actinomyces presence was not a predictive factor for recurrence of any type of osteonecrosis. To predict recurrence and healing delays, more parameters need to be investigated.
영문 초록
목차
I. Introduction
II. Materials and Methods
III. Results
IV. Discussion
V. Conclusion
References
키워드
해당간행물 수록 논문
참고문헌
최근 이용한 논문
교보eBook 첫 방문을 환영 합니다!
신규가입 혜택 지급이 완료 되었습니다.
바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!
